Haemonetics to Present at the 33rd Annual J.P. Morgan Health Care Conference
PR Newswire - Mon Dec 22, 3:00PM CST
Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at the 33rd Annual J.P. Morgan Health Care Conference in San Francisco on Tuesday, January 13, 2015 at 4:30 pm Pacific time / 7:30 pm Eastern time.
JPM: 62.48 (unch), HAE: 38.11 (+0.30)
Haemonetics (HAE) Upgraded From Hold to Buy
at The Street - Sat Dec 13, 7:20AM CST
Haemonetics (HAE) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B.
HAE: 38.11 (+0.30)
Post Earnings Update: Haemonetics Has Climbed 6.9% Higher in Past 2 Weeks (HAE)
Comtex SmarTrend(R) - Mon Nov 17, 8:53AM CST
When Haemonetics (NYSE:HAE) reported earnings 14 days ago on November 3rd, 2014, analysts, on average, expected the company to report earnings of $0.45 on sales of $230.0 million. The company actually reported EPS of $0.47 on sales of $227.6 million, beating EPS estimates by $0.02 and missing revenue estimates by $2.4 million. Shares of Haemonetics have climbed from $34.74 to $37.13, representing a gain of 6.9% since the company reported earnings 14 days ago.
HAE: 38.11 (+0.30)
Haemonetics to Present at the Jefferies 2014 Global Healthcare Conference
PR Newswire - Tue Nov 11, 3:00PM CST
Haemonetics Corporation (NYSE: HAE) announced today that Gerry Gould, Vice President, Investor Relations, will present at the Jefferies 2014 Global Healthcare Conference in London, England on November 20, 2014 at 8:40 am GMT.
HAE: 38.11 (+0.30)
Update: Haemonetics Needs A Sales Growth Infusion Following Q3 Sales Miss And EPS Beat
Martin Vlcek - at Seeking Alpha - Wed Nov 05, 8:56AM CST
HAE: 38.11 (+0.30)
NYSE stocks posting largest percentage decreases
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:
TLM.TO: 9.10 (-0.01), HLF: 37.98 (+0.20), FRM: 7.61 (unch), TLM: 7.84 (unch), AKS: 5.76 (+0.11), CIE: 8.79 (-0.25), RCAP: 11.23 (+0.26), GDP: 4.93 (-0.22), LRE: 7.00 (-0.20), HAE: 38.11 (+0.30), S: 4.19 (-0.05), SGY: 17.83 (-0.52), BAS: 7.30 (-0.08), GVA: 38.59 (-0.07), HELI: 3.37 (-0.21), AP: 19.03 (+0.47), CRK: 7.01 (-0.20)
Haemonetics Q2 Earnings Beat Estimates but Decline Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:20PM CST
Haemonetics Corporation (HAE) reported adjusted earnings of 47 cents per share in the second quarter of fiscal 2015.
BSX: 13.13 (+0.07), ICUI: 83.38 (+1.63), ABAX: 58.48 (+0.22), HAE: 38.11 (+0.30)
Haemonetics' (HAE) CEO Brian Concannon on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 03, 10:42AM CST
HAE: 38.11 (+0.30)
Haemonetics affirms revenue and earnings guidance after FQ2 results
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 6:54AM CST
HAE: 38.11 (+0.30)
Haemonetics beats 2Q profit forecasts
Automated Insights - Mon Nov 03, 5:18AM CST
BRAINTREE, Mass. (AP) _ Haemonetics Corp. (HAE) on Monday reported fiscal second-quarter earnings of $7.5 million.
HAE: 38.11 (+0.30)
Haemonetics beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 5:02AM CST
HAE: 38.11 (+0.30)
Haemonetics Reports 2nd Quarter Fiscal 2015 Revenue of $228 Million and Adjusted EPS of $0.47; Reaffirms Revenue and Earnings Guidance
PR Newswire - Mon Nov 03, 5:00AM CST
Haemonetics Corporation (NYSE: HAE) today reported second quarter fiscal 2015 revenue of $227.6 million, down 3.5%. In constant currency, revenue declined 2.6% in the quarter. The Company reported second quarter GAAP net income of $7.5 million and GAAP net income per share of $0.14. Exclusive of transformation, restructuring and deal amortization expenses detailed below, adjusted net income was $24.3 million and adjusted earnings per share were $0.47, both down 29%.[1]
HAE: 38.11 (+0.30)
Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:30PM CST
ACW: 4.30 (+0.01), SYY: 40.59 (-0.11), L: 42.37 (-0.20), EEP: 38.84 (+0.11), SNH: 22.07 (+0.04), INN: 12.47 (+0.03), ITG: 20.72 (-0.40), NSP: 34.53 (+0.01), S: 4.19 (-0.05), ALE: 55.81 (+0.61), GVA: 38.59 (-0.07), MCY: 55.84 (+0.68), ARNA: 3.57 (-0.01), CHD: 80.16 (-0.37), ARE: 89.23 (-0.23), USAK: 25.88 (+0.46), BWP: 17.53 (-0.14), KRG: 28.69 (-0.03), CYOU: 25.85 (+0.42), MNKD: 5.68 (+0.18), HNT: 53.73 (+0.02), AMH: 17.34 (-0.07), ARCB: 46.21 (-0.09), ANIP: 55.24 (+1.79), AMG: 213.80 (-0.27), HAE: 38.11 (+0.30), SOHU: 51.80 (-0.22), CNA: 38.93 (-0.06)
Haemonetics reports November 3
Seeking Alpha - at Seeking Alpha - Sat Nov 01, 4:46PM CDT
HAE: 38.11 (+0.30)
Is Haemonetics (HAE) Poised to Beat on Q2 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 5:15PM CDT
Haemonetics (HAE) has delivered positive earnings surprises in three of the past four quarters with an average beat of 1.9%
HAE: 38.11 (+0.30), HTWR: 72.62 (+0.02), HOLX: 26.89 (+0.10), HSP: 62.60 (-0.07)
3PEA International and Haemonetics Partner to Integrate PaySign Connect with Haemonetics' Donor Management System
Business Wire - Tue Oct 21, 7:49AM CDT
3PEA International, Inc. (OTCBB:TPNL)(OTCQB:TPNL), a vertically integrated provider of innovative prepaid card programs and processing services for corporate, consumer and government applications, today announced that 3PEA and Haemonetics Corporation (NYSE:HAE) have entered into an agreement whereby 3PEA International will integrate its PaySign(R) Connect prepaid debit card solution with Haemonetics' Donor Management System ("DMS"
HAE: 38.11 (+0.30)
Haemonetics Sets Date for Second Quarter Fiscal Year 2015 Earnings Release: November 3, 2014
PR Newswire - Mon Oct 06, 3:00PM CDT
Haemonetics Corporation (NYSE:HAE) will announce its earnings for the second quarter of its fiscal year 2015 on November 3, 2014 in a pre-market press release. The Company will host a webcast to discuss and answer questions about the press release at 8:00 am eastern time on November 3, 2014.
HAE: 38.11 (+0.30)
Perrigo Sells Some Assets to Imago Pharmaceuticals - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 3:45PM CDT
Perrigo (PRGO) has out licensed some of its early-stage assets.
BIIB: 340.89 (+5.13), PRGO: 166.11 (+1.96), ABAX: 58.48 (+0.22), HAE: 38.11 (+0.30)
Walgreens Earnings in Line, Alliance Boots Shows Synergy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 30, 9:45AM CDT
Walgreen Co. (WAG) reported adjusted net earnings of 74 cents per share in the fourth quarter of fiscal 2014.
ABAX: 58.48 (+0.22), HAE: 38.11 (+0.30), CVS: 97.89 (+0.02), WAG: 76.67 (+0.16)